Summit Partners Public Asset Management’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-148,386
Closed -$6.85M 110
2022
Q3
$6.85M Sell
148,386
-44,969
-23% -$2.21M 0.35% 74
2022
Q2
$8.34M Sell
193,355
-63,045
-25% -$2.88M 0.38% 68
2022
Q1
$13.8M Sell
256,400
-179,723
-41% -$9.18M 0.49% 66
2021
Q4
$26.1M Buy
436,123
+44,973
+11% +$2.8M 1% 37
2021
Q3
$25.6M Buy
391,150
+43,679
+13% +$2.84M 0.8% 49
2021
Q2
$22M Sell
347,471
-70,946
-17% -$4.08M 0.78% 53
2021
Q1
$20.4M Sell
418,417
-259,738
-38% -$12.5M 0.88% 47
2020
Q4
$28M Buy
678,155
+136,986
+25% +$6.28M 1.24% 26
2020
Q3
$24.9M Buy
541,169
+73,831
+16% +$3.43M 1.24% 29
2020
Q2
$20.5M Sell
467,338
-14,637
-3% -$658K 1.22% 25
2020
Q1
$19.1M Buy
481,975
+112,470
+30% +$5.04M 1.57% 19
2019
Q4
$17.4M Buy
+369,505
New +$14.3M 1.64% 25

Other funds holding KIDS

Summit Partners Public Asset Management's KIDS Position: Q4 2022 in Review

Summit Partners Public Asset Management sold out of OrthoPediatrics (KIDS) in Q4 2022, closing a stake of 148,386 shares — an estimated $6.85M sold.

Summit Partners Public Asset Management first reported a position in KIDS in Q4 2019 and held it in 12 quarters. The position peaked at $28M in Q4 2020. 118 funds tracked by Wall St. Rank hold KIDS as of Q4 2022.

  • Summit Partners Public Asset Management reported no remaining OrthoPediatrics position as of Q4 2022 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 148,386 OrthoPediatrics shares in Q4 2022, an estimated $6.85M.
  • Summit Partners Public Asset Management first reported a position in OrthoPediatrics in Q4 2019 and held it in 12 quarters.
  • Summit Partners Public Asset Management's OrthoPediatrics position peaked at $28M in Q4 2020.
  • 118 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2022.

Based on Summit Partners Public Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.